Over 50 Years of Excellence
World-Class Program in Pediatric Transplantation
The University of Minnesota is an internationally respected pioneer in the area of blood and marrow transplantation (BMT). The first successful human allogeneic bone marrow transplant was performed at the University of Minnesota in 1968. Other “firsts” include the first transplant to treat a patient with lymphoma (1975), the first transplant to treat an inherited metabolic disease (1982), and the world’s first umbilical cord blood transplant performed using pre-implantation genetic testing to ensure a perfect tissue match (2000). Our clinical program is recognized as the second largest unrelated donor transplant programs in the country, and one of the largest umbilical cord blood transplant centers worldwide.
Dedicated to exceptional and innovative blood and marrow transplantation patient care, research, and education
Under Medical Director John Wagner, M.D., we've continued pioneering leading-edge technology by University of Minnesota researchers and physicians. Our experience and achievements using umbilical cord blood transplantation as a treatment for high-risk acute leukemias and other metabolic diseases continues to develop with success. Our experience and achievements using umbilical cord blood transplantation as a treatment for high-risk acute leukemias and other diseases continues to develop with success.
We have treated more Fanconi Anemia patients with Blood and Marrow Transplantation than any other center in North America. Since 1976 we have performed sibling donor transplants for Fanconi Anemia and unrelated donor transplants for Fanconi Anemia since 1987. In 2000, we performed the world's first umbilical cord blood transplant on a Fanconi Anemia patient using preimplantation genetic testing to ensure a perfect tissue match.
Giving Hope to Families and Patients
Our experience, research and technology lead to success and renewed hope for thousands of patients all over the world treated over the last 50 years.